Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes

Shohei Fukada1, Kouji Ohta2, Miyuki Sakuma1

  • 1Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Oral Diseases
|November 30, 2022
PubMed
Abstract

Insights

Sunitinib causes oral keratinocyte injury and apoptosis through p38 activation and STAT3 downregulation. These cytotoxic effects may explain sunitinib-related oral complications in cancer patients.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Sunitinib is a tyrosine kinase inhibitor used for metastatic renal cell carcinoma.
  • Oral mucosal complications like stomatitis are common in patients treated with sunitinib.
  • The cytotoxic effects of sunitinib on oral keratinocytes are not well understood.

Purpose of the Study:

  • To investigate the effects of sunitinib on oral keratinocytes.
  • To elucidate the mechanisms of sunitinib-induced cell injury and apoptosis.
  • To identify the signaling pathways involved in sunitinib's effects on oral keratinocytes.

Main Methods:

  • Sunitinib's effects on immortalized oral keratinocytes (RT7 cells) and primary oral keratinocytes were assessed.
  • Cell injury was measured by lactate dehydrogenase (LDH) release.
  • Apoptosis was evaluated through DNA fragmentation, protein expression (Bcl-2, PARP, caspases), and Western blotting for signaling pathways (MAPK, STAT3).

Main Results:

  • Sunitinib significantly increased LDH release, indicating cell injury.
  • The drug induced apoptosis, evidenced by DNA fragmentation and altered expression of apoptosis-related proteins (Bcl-2, PARP, caspase 3/9).
  • Sunitinib increased p38 MAPK phosphorylation, decreased STAT3 phosphorylation, and these changes were linked to cell injury and apoptosis.

Conclusions:

  • Sunitinib induces cell injury and apoptosis in oral keratinocytes.
  • The mechanism involves p38 MAPK activation and STAT3 downregulation.
  • These findings suggest sunitinib's cytotoxic effects on oral keratinocytes contribute to oral complications during cancer therapy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K